RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Roche Holding AG

A collection of news and information related to Roche Holding AG published by this site and its partners.

Top Roche Holding AG Articles see all

Displaying items 1-5
  • New help for basal cell skin cancer patients

     
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell carcinoma, the
  • FDA approves Bristol-Myers' immunotherapy for skin cancer

    The U.S. Food and Drug Administration approved Bristol-Myers Squibb Co's skin cancer drug, more than three months before the scheduled review date. Opdivo, or nivolumab, belongs to a promising new class of drugs designed to help the body's own immune...

    Database shows $3.5 billion in industry ties to doctors, hospitals

    Database shows $3.5 billion in industry ties to doctors, hospitals
    Pulling the curtain back on long-hidden industry relationships, the federal government revealed that U.S. doctors and teaching hospitals had $3.5 billion worth of financial ties with drug and medical-device makers in the last five months of 2013. The...

    New study may deal final blow to acne drug Accutane

    New study may deal final blow to acne drug Accutane
    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition. -------------------- FOR THE RECORD: Accutane's side effects: An article in Saturday's Section A about the possibility of...

    Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Hepatitis-C Drug OK'd, Promising More Cures
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...